TAMARA BARLAGE: Open Payments
NPI 1831771336 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,080 in 100 payments from 22 companies in 2025. Trend: 2023 $1,192 · 2024 $1,579 · 2025 $2,080
Food & beverage: $2,080
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $481 |
| Lilly USA, LLC | 10 | $262 |
| Axsome Therapeutics, Inc. | 8 | $179 |
| Neurocrine BioSciences, Inc. | 13 | $171 |
| Eisai Inc. | 2 | $138 |
| ARGENX US, INC. | 4 | $111 |
| Genentech USA, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| UCB, Inc. | 4 | $84 |
| Neurelis, Inc. | 3 | $57 |
Products named: QULIPTA, Symbravo, INGREZZA, Leqembi, KISUNLA, HYQVIA, AMYVID, UBRELVY.
Industry payments across OH — which companies pay providers there.
